Pfizer bags approval for RA drug Xeljanz
admin 27th March 2017 Uncategorised 0Some patients with moderate to severe forms of rheumatoid arthritis could get access to a new treatment option in Europe following the approval of Pfizer’s oral Janus kinase (JAK) inhibitor Xeljanz.
More: Pfizer bags approval for RA drug Xeljanz
Source: News